A citation-based method for searching scientific literature

J M Russell. Physiol Rev 2000
Times Cited: 650



Wolfgang Löscher, Martin Puskarjov, Kai Kaila. Neuropharmacology 2013
Times Cited: 171




List of shared articles



Times cited

Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
Philip Hampel, Kerstin Römermann, Björn Gailus, Marie Johne, Birthe Gericke, Edith Kaczmarek, Wolfgang Löscher. Neuropharmacology 2021
2

Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy.
Philip Hampel, Marie Johne, Björn Gailus, Alexandra Vogel, Alina Schidlitzki, Birthe Gericke, Kathrin Töllner, Wiebke Theilmann, Christopher Käufer, Kerstin Römermann,[...]. Neurobiol Dis 2021
1

Impaired chloride homeostasis in epilepsy: Molecular basis, impact on treatment, and current treatment approaches.
Theresa Auer, Philipp Schreppel, Thomas Erker, Christoph Schwarzer. Pharmacol Ther 2020
12

NKCC1, an Elusive Molecular Target in Brain Development: Making Sense of the Existing Data.
Mari A Virtanen, Pavel Uvarov, Christian A Hübner, Kai Kaila. Cells 2020
5

Horizontal Cell Feedback to Cone Photoreceptors in Mammalian Retina: Novel Insights From the GABA-pH Hybrid Model.
Steven Barnes, James C R Grove, Cyrus F McHugh, Arlene A Hirano, Nicholas C Brecha. Front Cell Neurosci 2020
3

Novel hybrid action of GABA mediates inhibitory feedback in the mammalian retina.
James C R Grove, Arlene A Hirano, Janira de Los Santos, Cyrus F McHugh, Shashvat Purohit, Greg D Field, Nicholas C Brecha, Steven Barnes. PLoS Biol 2019
11

Seasonal plasticity in GABAA signaling is necessary for restoring phase synchrony in the master circadian clock network.
Kayla E Rohr, Harshida Pancholi, Shabi Haider, Christopher Karow, David Modert, Nicholas J Raddatz, Jennifer Evans. Elife 2019
8

Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Claudia Brandt, Patricia Seja, Kathrin Töllner, Kerstin Römermann, Philip Hampel, Markus Kalesse, Andi Kipper, Peter W Feit, Kasper Lykke, Trine Lisberg Toft-Bertelsen,[...]. Neuropharmacology 2018
23